Journal of Clinical Oncology , 0732-183X

Journal

1 - 10 out of 120Page size: 10

Publications

  1. 1999
  2. Published

    Mitomycin, ifosfamide, and cisplatin in unresectable non-small-cell lung cancer: effects on survival and quality of life

    Lucinda Billingham, David Ferry, Oct 1999, In: Journal of Clinical Oncology . 17, 10, p. 3188-94 7 p.

    Research output: Contribution to journal › Article › peer-review

  3. 2000
  4. Published

    Quality of life in non-small-cell lung cancer

    Lucinda Billingham, Apr 2000, In: Journal of Clinical Oncology . 18, 8, p. 1802

    Research output: Contribution to journal › Article › peer-review

  5. 2001
  6. Published

    Ascertainment of the incidence of Beckwith-Wiedemann syndrome in the National Wilms Tumor Study Group

    Richard Grundy, 1 Jan 2001, In: Journal of Clinical Oncology. 19, 2, p. 593-593 1 p.

    Research output: Contribution to journal › Article

  7. Published

    Marimastat as first line therapy for patients with unresectable pancreatic cancer - A randomised trial

    Simon Bramhall, 1 Jan 2001, In: Journal of Clinical Oncology. 19, 15, p. 3447-3455 9 p.

    Research output: Contribution to journal › Article

  8. 2002
  9. Published

    ZD1839, a selective oral epidermal growth factor receptor-tyrosine kinase inhibitor, is well tolerated and active in patients with solid, malignant tumors: results of a phase I trial

    David Ferry, Phil Murray, 2002, In: Journal of Clinical Oncology. 20, 9, p. 2240-50 11 p.

    Research output: Contribution to journal › Article › peer-review

  10. Published

    Missense mismatch repair gene alterations, microsatellite instability and hereditary nonpolyposis colorectal cancer

    Emilio Porfiri, 1 Jan 2002, In: Journal of Clinical Oncology. 20, p. 3178-3179 2 p.

    Research output: Contribution to journal › Letter

  11. Published

    Mutations of hMSH2 and hMLH1 in patients with suspected hereditary non-polyposis colorectal cancer (HNPCC)

    Emilio Porfiri, 1 Mar 2002, In: Journal of Clinical Oncology. 20, p. 1203-1208 6 p.

    Research output: Contribution to journal › Article

  12. Published

    Hepatic drug targeting: Phase I evaluation of polymer-bound doxorubicin

    Leonard Seymour, David Ferry, Annie Young & David Kerr, 15 Mar 2002, In: Journal of Clinical Oncology. 20, 6, p. 1668-1676 9 p.

    Research output: Contribution to journal › Article

  13. Published

    Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: Progression-free survival analysis of a Phase III randomised trial

    Philip Johnson, 15 Apr 2002, In: Journal of Clinical Oncology. 20, 8, p. 2038-2044 7 p.

    Research output: Contribution to journal › Article

  14. Published

    ZD1839, a selective oral epidermal growth factor receptor-tyrosine kinase inhibitor, is well tolerated and active in patients with solid, malignant tumours: Results of a Phase I trial

    Lisette Hammond, David Ferry, Phil Murray, 1 May 2002, In: Journal of Clinical Oncology. 20, 9, p. 2240-2250 11 p.

    Research output: Contribution to journal › Article

Previous 1 2 3 4 5 6 7 8 ...12 Next